Ergogenic effects of low doses of caffeine on cycling performance.
The purpose of this experiment was to learn whether low doses of caffeine have ergogenic, perceptual, and metabolic effects during cycling. To determine the effects of 1, 2, and 3 mg/kg caffeine on cycling performance, differentiated ratings of perceived exertion (D-RPE), quadriceps pain intensity, and metabolic responses to cycling exercise, 13 cyclists exercised on a stationary ergometer for 15 min at 80% VO, then, after 4 min of active recovery, completed a 15-min VO2peak performance ride 60 min after ingesting caffeine or placebo. Work done (kJ/kg) during the performance ride was used as a measure of performance. D-RPE, pain ratings, and expired-gas data were obtained every 3 min, and blood lactate concentrations were obtained at 15 and 30 min. Compared with placebo, caffeine doses of 2 and 3 mg/kg increased performance by 4% (95% CI: 1.0-6.8%, p = .02) and 3% (95% CI: -0.4% to 6.8%, p = .077), respectively. These effects were ergogenic, on average, but varied considerably in magnitude among individual cyclists. There were no effects of caffeine on D-RPE or pain throughout the cycling task. Selected metabolic variables were affected by caffeine, consistent with its known actions. The authors conclude that caffeine preparations of 2 and 3 mg/kg enhanced performance, but future work should aim to explain the considerable interindividual variability of the drug's ergogenic properties.
Department of Kinesiology, University of Georgia, Athens, GA 30602, USA.
Nathan T
NT
Jenkins
Jennifer L
JL
Trilk
Arpit
A
Singhal
Patrick J
PJ
O'Connor
Kirk J
KJ
Cureton
D000328:Adult; D001642:Bicycling / Q000502:physiology*; D002110:Caffeine / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D005080:Exercise Test; D005221:Fatigue; D006801:Humans; D007773:Lactates / Q000097:blood; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000294:innervation; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology; D010101:Oxygen Consumption / Q000187:drug effects; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010147:Pain Measurement; D017288:Pain Threshold; D010465:Perception; D005082:Physical Exertion / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D007773:Lactates; D002110:Caffeine